Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(+)-PD 128907 is a potent agonist of the dopamine 3 (D3) receptor (Ki = 1 nM).1,2 It shows selectivity for D3 over D2 and D4 receptors (Kis = 1.2 and 7 µM, respectively).1 Low doses of (+)-PD 128907 (13 µg/kg, s.c.) reduce spontaneous locomotor activity in rats.3 It blocks stereotypy induced by the NMDA receptor antagonist (+)-MK-801 (Item No. 10009019) in mice.4 (+)-PD 128907 is used in animal models to study the role of the D3 receptor in nervous system disorders, such as schizophrenia, Parkinson’s disease, and depression.5,6
WARNING This product is not for human or veterinary use.
1. Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-
2. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275(3), 1355-1366 (1995).
3. The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-
4. Atypical antipsychotic-
5. Implication of dopamine D3 receptor activation in the reversion of Parkinson’s disease-
6. An amino acid residue in the second extracellular loop determines the agonist-